Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Morrison

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
Molecular Immunology|March 6, 1998
Amino acid differences in the N-terminus of C(H)2 influence the relative abilities of IgG2 and IgG3 to activate complementM G Sensel, L M Kane, S L Morrison
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activityL S Peng, M L Penichet, S L Morrison
Plant Physiology|September 1, 1983
Ultraviolet-Stimulated KHCO(3) Efflux from Rose Cells: Regulation of Cytoplasmic pHT M Murphy, G B Matson, S L Morrison
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1995
Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4R I Smith, M J Coloma, S L Morrison
Human Antibodies|January 1, 1997
Antibody-IL-2 fusion proteins: a novel strategy for immune protectionM L Penichet, E T Harvill, S L Morrison
The Journal of Experimental Medicine|August 1, 1993
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activationM H Tao, R I Smith, S L Morrison
The Journal of Biological Chemistry|April 14, 1995
Structure and function of several anti-dansyl chimeric antibodies formed by domain interchanges between human IgM and mouse IgG2bP H Poon, S L Morrison, V N Schumaker
The Journal of Experimental Medicine|April 1, 1991
The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domainM H Tao, S M Canfield, S L Morrison
Nucleic Acids Research|December 1, 1991
The plasmacytoma J558L lacks constitutively active NF-kappa B and is deficient in early response gene activationM T Anderson, L A Wims, S L Morrison
The Journal of Experimental Medicine|September 1, 1988
Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigenS C Wallick, E A Kabat, S L Morrison
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
Molecular Immunology|March 6, 1998
Amino acid differences in the N-terminus of C(H)2 influence the relative abilities of IgG2 and IgG3 to activate complementM G Sensel, L M Kane, S L Morrison
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activityL S Peng, M L Penichet, S L Morrison
Plant Physiology|September 1, 1983
Ultraviolet-Stimulated KHCO(3) Efflux from Rose Cells: Regulation of Cytoplasmic pHT M Murphy, G B Matson, S L Morrison
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1995
Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4R I Smith, M J Coloma, S L Morrison
Human Antibodies|January 1, 1997
Antibody-IL-2 fusion proteins: a novel strategy for immune protectionM L Penichet, E T Harvill, S L Morrison
The Journal of Experimental Medicine|August 1, 1993
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activationM H Tao, R I Smith, S L Morrison
The Journal of Biological Chemistry|April 14, 1995
Structure and function of several anti-dansyl chimeric antibodies formed by domain interchanges between human IgM and mouse IgG2bP H Poon, S L Morrison, V N Schumaker
The Journal of Experimental Medicine|April 1, 1991
The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domainM H Tao, S M Canfield, S L Morrison
Nucleic Acids Research|December 1, 1991
The plasmacytoma J558L lacks constitutively active NF-kappa B and is deficient in early response gene activationM T Anderson, L A Wims, S L Morrison
The Journal of Experimental Medicine|September 1, 1988
Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigenS C Wallick, E A Kabat, S L Morrison
Pageof 19